Safety and cost-effectiveness of single dose dispensing of bevacizumab for various retinal pathologies in developing countries.
Indian J Ophthalmol
; 2007 Nov-Dec; 55(6): 488-90
Article
in En
| IMSEAR
| ID: sea-70911
Full text:
1
Index:
IMSEAR
Main subject:
Retinal Diseases
/
Humans
/
Cost-Benefit Analysis
/
Angiogenesis Inhibitors
/
Developing Countries
/
Dose-Response Relationship, Drug
/
Drug Packaging
/
Drug Dosage Calculations
/
Antibodies, Monoclonal
Type of study:
Health_economic_evaluation
Language:
En
Journal:
Indian J Ophthalmol
Year:
2007
Type:
Article